Advertisement
Global Market Insights

Bank of Japan Chief Ueda Hospitalized, June 11 Rate Decision Proceeds

June 11, 2026
12:01 PM
3 min read

Key Points

Bank of Japan Governor Ueda hospitalized June 9 for liver cyst infection treatment, expected stay two weeks.

Rate hike to 1.0% proceeds June 15-16 with eight board members voting, first increase in 31 years.

Dollar-yen pair rises to 160.47 as market sells yen on policy uncertainty and Ueda's absence.

Meyka rates BOJ stock 8301.T a D+ strong sell, down 9.4% over one year amid weak metrics.

Be the first to rate this article

Bank of Japan Governor Kazuo Ueda entered hospital on June 9 for treatment of a liver cyst infection. The BOJ announced on June 10 that Ueda will miss the June 15-16 monetary policy meeting, the first time a sitting governor has skipped a regular session since 1998. Deputy Governor Yoshimasa Hayashi will chair the meeting. The rate decision will proceed with eight policy board members voting. A 0.25% rate hike to 1.0% is widely expected.

Advertisement

Why the Governor’s Absence Matters

Ueda’s hospitalization comes at a critical moment for Japan’s monetary policy. The BOJ plans to raise the policy rate from 0.75% to 1.0%, the first increase in 31 years. Ueda will submit written opinions but cannot vote. Deputy Governor Yoshimasa Hayashi will chair the meeting, while Deputy Governor Shinichi Uchida will lead the post-decision press conference. The BOJ said Ueda expects to return for the July 30-31 meeting.

Market Reaction and Rate Hike Outlook

The yen weakened after news of Ueda’s hospitalization. The dollar-yen pair rose to 160.47 yen per dollar on June 10. Analysts expect the rate hike to proceed unchanged. The BOJ has already signaled its intent to raise rates due to rising inflation from Middle East oil tensions. With eight board members voting instead of nine, the hike faces no real obstacle to approval.

What This Means for Bank of Japan Stock

The BOJ confirmed only that Ueda has a liver cyst infection, with no details on the cause or severity. Meyka rates 8301.T a D+ with a strong sell recommendation based on weak financial metrics. The stock trades at ¥24,000, down 9.4% over one year. Policy uncertainty from Ueda’s absence poses short-term risk, though the rate hike remains on track.

Liver Cyst Infection Details

A liver cyst infection occurs when bacteria invade fluid-filled pockets in the liver. The BOJ said Ueda’s hospitalization is expected to last about two weeks. Symptoms of severe liver disease include sudden fatigue, loss of appetite, and jaundice. The BOJ did not disclose the infection’s cause or Ueda’s prior medical history. Ueda will continue work remotely during his hospital stay.

Advertisement

Final Thoughts

Ueda’s absence does not derail the planned rate hike to 1.0%, expected to pass with eight board members voting. Yen weakness on the news reflects market concern over policy clarity, but the BOJ’s monetary tightening cycle remains intact.

FAQs

Will the rate hike still happen without Governor Ueda?

Yes. The eight remaining policy board members will vote on the rate increase to 1.0%. The BOJ has already signaled its intent due to inflation concerns.

What is a liver cyst infection?

Bacteria invade fluid-filled pockets in the liver, causing infection. The BOJ disclosed only the diagnosis, not the severity or specific cause of Ueda’s condition.

When will Governor Ueda return to work?

The BOJ expects Ueda to return for the July 30-31 policy meeting after approximately two weeks hospitalization. He will handle remote work during his absence.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.

About Author

Author

Huzaifa Zahoor

Co Founder

Huzaifa Zahoor is the engineer who built Meyka. He has spent years writing Python, training AI models, and building data pipelines specifically for financial markets. His technical articles have reached over 30,000 readers on Medium, so he knows how to make complex things easy to follow. If this article touches on how the tools work, he is the person who actually built them.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)